Exploiting Canonical TGFβ Signaling in Cancer Treatment

Clinical benefits from targeting TGFβ in cancer remain elusive. Liu et al review mechanisms by which TGFβ acts to oppose #CancerTherapy, the prognostic and predictive value of TGFβ #biomarkers and the potential impact of TGFβ inhibition. https://t.co/SizSh

Clinical benefits from targeting TGFβ in cancer remain elusive. Liu et al review mechanisms by which TGFβ acts to oppose #CancerTherapy, the prognostic and predictive value of TGFβ #biomarkers and the potential impact of TGFβ inhibition. https://t.co/zWBtJ